You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • AB0502 Serum matrix metalloproteinase-3 levels indicate c-reactive protein as one of boolean remission core measure sets in patients with rheumatoid arthritis by using anti-TNFα treatment

Article info

Article menu
Download PDFPDF
Scientific Abstracts
Abstracts accepted for publication
Rheumatoid arthritis – anti-TNF therapy
AB0502 Serum matrix metalloproteinase-3 levels indicate c-reactive protein as one of boolean remission core measure sets in patients with rheumatoid arthritis by using anti-TNFα treatment

Authors

Citation

Hattori Y, Kaneko A, Kojima T, et al
AB0502 Serum matrix metalloproteinase-3 levels indicate c-reactive protein as one of boolean remission core measure sets in patients with rheumatoid arthritis by using anti-TNFα treatment
Annals of the Rheumatic Diseases 2013;71:666.

Publication history

  • First published January 23, 2014.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions